Monitoring of efficacy, tolerability and safety of artemether–lumefantrine and artesunate–amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Lambaréné, Gabon: an open-label clinical trial

BACKGROUND: Malaria remains a major public health problem, affecting mainly low-and middle-income countries. The management of this parasitic disease is challenged by ever increasing drug resistance. This study, investigated the therapeutic efficacy, tolerability and safety of artemether–lumefantrin...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Malar J
Auteurs principaux: Adegbite, Bayode R., Edoa, Jean R., Honkpehedji, Yabo J., Zinsou, Frejus J., Dejon-Agobe, Jean C., Mbong-Ngwese, Mirabeau, Lotola-Mougueni, Fabrice, Koehne, Erik, Lalremruata, Albert, Kreidenweiss, Andrea, Nguyen, The T., Kun, Jutta, Agnandji, Selidji T., Lell, Bertrand, Safiou, Abdou R., Obone Atome, Fridia A., Mombo-Ngoma, Ghyslain, Ramharter, Michael, Velavan, Thirumalaisamy P., Mordmüller, Benjamin, Kremsner, Peter G., Adegnika, Ayola A.
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2019
Sujets:
Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6916217/
https://ncbi.nlm.nih.gov/pubmed/31842893
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12936-019-3015-4
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires